<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000351.v1.p1" parentStudy="phs000351.v1.p1" createDate="2011-03-22" modDate="2011-05-13">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Mark Purdue</td><td>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</td></tr>
		<tr><td>Study Representatives</td><td>Demetrius Albanes</td><td>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</td></tr>
		<tr><td>Study Representatives</td><td>Wong-Ho Chow</td><td>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</td></tr>
		<tr><td>Study Representatives</td><td>Victoria Stevens</td><td>Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA</td></tr>
		<tr><td>Genomics</td><td>Stephen Chanock</td><td>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NCI Genome-Wide Association Study of Renal Cell Carcinoma</StudyNameEntrez>
	<StudyNameReportPage>National Cancer Institute Genome-Wide Association Study of Renal Cell Carcinoma</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The National Cancer Institute (NCI) genome-wide association study (GWAS) of renal cell carcinoma (RCC) was conducted to 	investigate common genetic variants associated with RCC risk.  The GWAS includes 1,453 RCC cases and 3,531 controls of 	European background from 4 studies (3 cohort, 1 case-control), scanned using the Illumina InfiniumHumanHap 550, 610 	and 660W chips.  This project was supported by the Intramural Research Program of the National Institutes of Health 	and NCI.</p> 	<p>Data from this GWAS were pooled with those from another GWAS of RCC (2,639 cases and 5,392 controls) conducted in 	Europe by the International Agency for Research on Cancer and the Centre National de G&#232;notypage.  Findings from this 	collaboration are described in an upcoming report (Purdue et al. Nature Genetics 2011;43(1):60-65; PMID:    <a href="http://www.ncbi.nlm.nih.gov/pubmed/21131975" target="_blank">21131975</a>).</p> 	<p>Only data from the NCI scan are included in this dbGaP submission.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Inclusion criteria: 		<ul> 			<li>Non-Hispanic Caucasian race</li> 			<li>Adequate consent for GWAS</li> 			<li>Cases: diagnosis of pathologically confirmed renal cancer (International Classification of Diseases for Oncology, 			Second Edition, Topography C64).</li> 		</ul> 	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21131975"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Carcinoma, Renal Cell"/>
		<Disease vocab_source="MESH" vocab_term="Kidney Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Mark Purdue</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Study Representatives">
			<AttName>Demetrius Albanes</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Study Representatives">
			<AttName>Wong-Ho Chow</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Study Representatives">
			<AttName>Victoria Stevens</AttName>
			<Institution>Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA</Institution>
		</Header>
		<Header title="Genomics">
			<AttName>Stephen Chanock</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Genomics">
			<AttName>Kevin Jacobs</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Coordination">
			<AttName>Nathaniel Rothman</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Coordination">
			<AttName>Lee Moore</AttName>
			<Institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>Of the 4 studies participating in the NCI GWAS of RCC, 3 are prospective cohorts and 1 is a case-control study.  The studies are:</p> 	<p><b>Cohorts:</b><br/> 	Alpha-Tocopherol and Beta-Carotene Cancer Prevention Study (ATBC)<br/> 	American Cancer Society Cancer Prevention Study-II (CPS-II)<br/> 	Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) 	</p> 	<p><b>Case-control:</b><br/> 	National Cancer Institute United States Kidney Cancer Study (USKC) 	</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="CADM" longName="Cancer in all age groups, other diseases in adults only, and methods (CADM)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>CGEMS</DacName>
      <DacFullName>Cancer Genetic Markers of Susceptibility (CGEMS) DAC</DacFullName>
      <DacEmail>NCI_CGEMS_DAC@mail.nih.gov </DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-480-3915</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000351.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000351.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000351.v1.p1" FileName="RenalDUC.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Cancer in all age groups, other diseases in adults only, and methods (CADM)</ConsentName>
        <ConsentAbbrev>CADM</ConsentAbbrev>
        <UseLimitation>The informed consent document signed by the participants allows use of these data by investigators for discovery and hypothesis generation in the investigation of the genetic contributions to cancer in all age groups and other diseases in adults only, as well as development of novel analytical approaches for GWAS.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd003532.1" type="protocol" createDate="2011-04-12" modDate="2011-04-12" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003532.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000351.v1.p1&amp;phd=3532">
      <OrigName>renal_GWAS_supplementary_methods.docx</OrigName>
      <DisplayName>Renal GWAS Supplementary Methods</DisplayName>
      <Description>Renal GWAS Supplementary Methods</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
